Therapeutic and diagnostic applications of dendrimers for cancer treatment

被引:418
作者
Wolinsky, Jesse B. [1 ]
Grinstaff, Mark W. [1 ]
机构
[1] Boston Univ, Dept Biomed Engn & Chem, Boston, MA 02215 USA
关键词
dendrimer; local therapy; nanoparticle; cancer treatment; drug-conjugates; drug delivery;
D O I
10.1016/j.addr.2008.02.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dendrimers are prepared with a level of control not attainable with most linear polymers, leading to nearly monodisperse, globular macromolecules with a large number of peripheral groups. As a consequence, dendrimers are an ideal delivery vehicle candidate for explicit study of the effects of polymer size, charge, composition, and architecture on biologically relevant properties such as lipid bilayer interactions, cytotoxicity, internalization, blood plasma retention time, biodistribution, and tumor uptake. Over the last several years, substantial progress has been made towards the use of dendrimers for therapeutic and diagnostic purposes for the treatment of cancer, including advances in the delivery of anti-neoplastic and contrast agents, neutron capture therapy, photodynamic therapy, and photothermal therapy. The focus of this review is on dendrimer developments from the last four years for oncological applications, with emphasis on distinct architectures and the biological responses these structures elicit. (c) 2008 Published by Elsevier B.V.
引用
收藏
页码:1037 / 1055
页数:19
相关论文
共 113 条
[51]   Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging [J].
Langereis, S ;
de Lussanet, QG ;
van Genderen, MHP ;
Meijer, EW ;
Beets-Tan, RGH ;
Griffioen, AW ;
van Engelshoven, JMA ;
Backes, WH .
NMR IN BIOMEDICINE, 2006, 19 (01) :133-141
[52]   A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas [J].
Lee, Cameron C. ;
Gillies, Elizabeth R. ;
Fox, Megan E. ;
Guillaudeu, Steven J. ;
Frechet, Jean M. J. ;
Dy, Edward E. ;
Szoka, Francis C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (45) :16649-16654
[53]   Designing dendrimers for biological applications [J].
Lee, CC ;
MacKay, JA ;
Fréchet, JMJ ;
Szoka, FC .
NATURE BIOTECHNOLOGY, 2005, 23 (12) :1517-1526
[54]   Silver/dendrimer nanocomposites as biomarkers: Fabrication, characterization, in vitro toxicity, and intracellular detection [J].
Lesniak, W ;
Bielinska, AU ;
Sun, K ;
Janczak, KW ;
Shi, XY ;
Baker, JR ;
Balogh, LP .
NANO LETTERS, 2005, 5 (11) :2123-2130
[55]   Immunotargeted nanoshells for integrated cancer imaging and therapy [J].
Loo, C ;
Lowery, A ;
Halas, NJ ;
West, J ;
Drezek, R .
NANO LETTERS, 2005, 5 (04) :709-711
[56]   Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy [J].
Majoros, IJ ;
Thomas, TP ;
Mehta, CB ;
Baker, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) :5892-5899
[57]   PAMAM dendrimer-based multifunctional conjugate for cancer therapy: Synthesis, characterization, and functionality [J].
Majoros, IJ ;
Myc, A ;
Thomas, T ;
Mehta, CB ;
Baker, JR .
BIOMACROMOLECULES, 2006, 7 (02) :572-579
[58]  
MALIK N, 2001, Patent No. 7005124
[59]   Lipid bilayer disruption by polycationic polymers: The roles of size and chemical functional group [J].
Mecke, A ;
Majoros, IJ ;
Patri, AK ;
Baker, JR ;
Holl, MMB ;
Orr, BG .
LANGMUIR, 2005, 21 (23) :10348-10354
[60]   Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers [J].
Mecke, A ;
Lee, DK ;
Ramamoorthy, A ;
Orr, BG ;
Holl, MMB .
LANGMUIR, 2005, 21 (19) :8588-8590